This document discusses albumin and direct bilirubin testing. It provides details on:
1) Albumin is synthesized in the liver and maintains fluid balance and transports substances through binding. Clinical applications include measuring glycated albumin as an indicator of short-term glucose control.
2) Direct bilirubin testing methods are based on the reaction of bilirubin with diazotized sulfanilic acid to form a colored product.
3) Elevated or decreased albumin and direct bilirubin levels can indicate various disease states.
This document discusses albumin and direct bilirubin testing. It provides details on:
1) Albumin is synthesized in the liver and maintains fluid balance and transports substances through binding. Clinical applications include measuring glycated albumin as an indicator of short-term glucose control.
2) Direct bilirubin testing methods are based on the reaction of bilirubin with diazotized sulfanilic acid to form a colored product.
3) Elevated or decreased albumin and direct bilirubin levels can indicate various disease states.
This document discusses albumin and direct bilirubin testing. It provides details on:
1) Albumin is synthesized in the liver and maintains fluid balance and transports substances through binding. Clinical applications include measuring glycated albumin as an indicator of short-term glucose control.
2) Direct bilirubin testing methods are based on the reaction of bilirubin with diazotized sulfanilic acid to form a colored product.
3) Elevated or decreased albumin and direct bilirubin levels can indicate various disease states.
FINALS: • half-life is 20 days: glycated albumin represents
serum glucose patterns approximating 1 month.
ACTIVITY OUTLINE • Albumin METHODS: • Direct Bilirubin • Affinity chromatographic methods: • Capillary puncture o based on specific interaction of boronic acids with glycated proteins have ALBUMIN o to determine serum concentrations of glycated albumin. • synthesized in the liver from 585 amino acids at the rate of 9 to 12 g/d with no reserve or storage. PRINCIPLE COMMENT • A protein present in highest concentration in the plasma. Globulins are • exists in the extravascular (interstitial) space. precipitated in high Labor o total extravascular albumin exceeds the total salt concentrations; intensive intravascular amount by 30% albumin in ▪ concentration of albumin: plasma Salt supernatant is albumin concentration = intravascular precipitation quantitated by albumin mass/plasma volume in the biuret reaction blood is much greater than its concentration in the interstitial space. DYE BINDING: • TRANSCAPILLARY ESCAPE RATE: Albumin leaves the circulation at a rate of 4% to 5% of total intravascular albumin per hour. Methyl orange Nonspecific o measures systemic capillary efflux of albumin. HABA Many • Albumin is responsible for 80% of the colloid [2,4′- Albumin binds to interference osmotic pressure (COP) of the intravascular fluid hydroxyazoben dye; causes shift in (salicylates, o maintains the appropriate fluid balance in zenebenzoic absorption bilirubin) the tissue acid] maximum • Albumin buffers pH and is a negative acute-phase BCG Sensitive; reactant protein. (bromocresol overestimates • Capacity to bind various substances in the blood green) low albumin o 4 binding sites on albumin have varying levels; most specificities for different substances. commonly • Albumin transports thyroid hormones; other used dye hormones, particularly fat -soluble ones; iron; and fatty acids. BCP Specific, • For example, albumin binds unconjugated (bromocresol sensitive, bilirubin, salicylic acid (aspirin), fatty acids, calcium purple) precise (Ca2+) and magnesium (Mg2+) ions, and many Accurate; drugs, and serum albumin levels can affect the Proteins separated gives overview half-life of drugs. This binding characteristic is also Electrophoresis based on electric of relative exhibited with certain dyes, providing a method charge changes in for the quantitation of albumin. different • clinical applications of glycated (or glycosylated) protein albumin as a more sensitive indicator of short- fractions term hyperglycemic control. o Glycated hemoglobin represents trends in CLINICAL SIGNIFICANCE: serum glucose over a period of 3 months DECREASE: or approximately 120 days (the life span of red blood cells [RBCs]). • malnutrition & malabsorption o inadequate source of amino acids • Liver disease • Obstructive jaundice (INCREASE) alpha - o resulting in decreased synthesis by the 2-beta globulins hepatocytes. o increase in globulins that occurs in early cirrhosis, however, balances the loss in albumin to give a total protein concentration within acceptable limits • Protein-losing enteropathy/ gastrointestinal loss as interstitial fluid leaks out in inflammation and disease of the intestinal tract as in diarrhea • Kidney loss of albumin via urine in renal disease. Albumin is normally excreted in very small amounts. This excess excretion occurs when the glomerulus no longer functions to restrict the passage of INCREASE Dehydration proteins from the blood as in nephrotic syndrome • Skin loss in the absence of the skin barrier such as in NORMAL • Immunodeficiency syndromes burns or exfoliative dermatitis • Multiple myeloma • Hypothyroidism • Monoclonal and polyclonal • Dilution by excess: polydipsia (drinking too much gammopathies water) or excess administration of intravenous fluids REFERENCE RANGE: 3.5 – 5.3 G/DL • Acute disease states • AUTOSOMAL RECESSIVE TRAIT: DIRECT BILIRUBIN o analbuminemia “absence of albumin” o bisalbuminemia “presence of albumin” • Ehrlich in 1883: “CLASSIC DIAZON REACTION” has unusual molecular characteristics o The reaction of bilirubin with a diazotized demonstrated by the presence of two albumin sulfanilic acid solution to form a colored bands instead of the single band usually seen product using urine samples. by electrophoresis. BOTH ARE RARE. • In 1913, van den Bergh: the diazo reaction may be • Redistribution by hemodilution, increased capillary applied to serum samples but only in the presence permeability (increased interstitial albumin), or of an accelerator (solubilizer) (ERROR) decreased lymph clearance. • In 1937 Malloy and Evelyn: the first clinically useful o Sepsis: a profound reduction in plasma albumin associated with marked fluid shifts. INCREASE: seldom clinically important • seen only with dehydration or after excessive albumin infusion methodology of quantitation of bilirubin in serum samples using the classic diazo reaction with a 50% DISEASE methanol solution as an accelerator. • Burns • In 1938, Jendrassik and Grof: a method using the • Trauma diazo reaction with caffeine-benzoate-acetate as • Infections an accelerator. • Acute (INCREASE) alpha 1 &2 globulins • PRESENT: Malloy and Evelyn: all commonly used • Chronic (INCREASE) alpha 1 &2 gamma methods for measuring bilirubin and its fractions globulins are modifications of the technique • Malabsorption • Total bilirubin and conjugated bilirubin (direct • Nephrotic syndrome bilirubin) are measured and unconjugated bilirubin DECREASE • Salt retention syndrome (indirect bilirubin) is determined by subtracting conjugated bilirubin from total bilirubin Hepatic damage: • Hepatitis (INCREASE) gamma globulins • Cirrhosis beta & gamma bridging • BILIRUBINOMETRY in the neonatal population. o only useful in the neonatal population; the o Serum: preferred for the Malloy-Evelyn presence of carotenoid compounds in adult > because the addition of the alcohol in the causes strong positive interference in the analysis can precipitate proteins and cause adult population. interference with the method. o Also, involves the measurement of reflected • fasting sample is preferred as the presence of light from the skin using two wavelengths lipemia will increase measured bilirubin that provide a numerical index based on concentrations. spectral reflectance. • HEMOLYZED SAMPLES SHOULD BE AVOIDED as o Newer generation bilirubinometers use they may decrease the reaction of bilirubin with the MICROSPECTROPHOTOMETERS diazo reagent. ▪ determine the optical densities of • Bilirubin is very sensitive to and is destroyed by bilirubin, hemoglobin, and melanin in light; should be protected from light. the subcutaneous layers of the infant’s o If left unprotected from light, bilirubin skin. values may reduce by 30% to 50% per hour. ▪ Mathematical isolation of hemoglobin o If serum or plasma is separated from the and melanin allows measurement of cells and stored in the dark, it is stable for 2 the optical density created by bilirubin. days at room temperature, 1 week at 4°C, When using the several methods described earlier, and indefinitely at −20°C. two of the “TOTAL BILIRUBIN: THREE FRACTIONS • There is no preferred reference method or OF BILIRUBIN” were identified: conjugated (direct) standardization of bilirubin analysis; the American and unconjugated (indirect) bilirubin. Association for Clinical Chemistry and the National • Unconjugated (indirect) bilirubin is a nonpolar and Bureau of Standards have published a candidate water-insoluble substance; found in plasma bound reference method for total bilirubin, “A MODIFIED to albumin. JENDRASSIK-GROF” procedure ▪ will only react with the diazotized sulfanilic o using caffeine-benzoate as a solubilizer; both acid solution (diazo reagent) in the presence have acceptable precision and are adapted to of an accelerator (solubilizer). many automated instruments • Conjugated (direct) bilirubin is a polar and water- • JENDRASSIK-GROF OR MALLOYEVELYN procedure soluble compound that is found in plasma in the is the most frequently used method to measure free state (not bound to any protein). bilirubin. ▪ will react with the diazotized sulfanilic acid JENDRASSIK-GROF METHOD: solution directly (without an accelerator). • slightly more complex • Conjugated and unconjugated bilirubin fractions • not affected by pH changes have been differentiated by solubility of the fractions. • Insensitive to a 50-fold variation in protein concentration of the sample • Direct and indirect bilirubin results should be reported as conjugated and unconjugated, • Maintains optical sensitivity even at low bilirubin respectively. concentrations • 3rd fraction of bilirubin “delta” bilirubin. A • Has minimal turbidity and a relatively constant conjugated bilirubin that is covalently bound to serum blank albumin. • Is not affected by hemoglobin up to 750 mg/dL o seen only when there is significant hepatic Because this chapter does not allow for a detailed obstruction; molecule is attached to albumin, description of all previously mentioned bilirubin test it is too large to be filtered by the glomerulus methodologies, only the most widely used and excreted in the urine. principles for measuring bilirubin in the adult and o when present, will react in most laboratory pediatric population are covered. methods as conjugated bilirubin. MALLOY-EVELYN: • pigments in serum or plasma are reacted with a SPECIMEN COLLECTION AND STORAGE: diazo reagent. • using a diazotized sulfanilic acid solution may be • diazotized sulfanilic acid reacts at the central performed on either serum or plasma. methylene carbon of bilirubin to split the molecule forming two molecules of azobilirubin. • at pH 1.2: the azobilirubin produced is red-purple in ▪ Proteins in serum are eliminated with color with a maximal absorption of 560 nm. saturated ammonium sulfate • most commonly used accelerator to solubilize (NH4)2SO4 and then bilirubin is unconjugated bilirubin is METHANOL, although reacted with diazotized sulfanilic acid other chemicals have been used. forming blue azorubilirubin using • MODIFICATION: alcoholic HCL as coupling promoter o Thamhauser–Andersen modification Reagents and results: ▪ direct reaction is made on the serum and • Saturated Ammonium Sulfate – protein the indirect on the alcoholic extract precipitant separated from serum after it has been • Alcoholic HCl – coupling promoter precipitated by ethyl alcohol and • Ehrlich’s diazo reagent – color reagent ammonium sulfate. • Blue azobilirubin at acid pH – end product and o Anino, Watson and ducci color JENDRASSIK-GROF METHOD FOR TOTAL AND MODIFICATIONS: Alkaline Methanolysis Method CONJUGATED BILIRUBIN DETERMINATION • used in researches only. • Bilirubin pigments in serum or plasma are reacted • MOST ACCURATE METHOD for measuring bilirubin with a diazo reagent (sulfanilic acid in hydrochloric o formation methyl esters and determination of acid and sodium nitrite), resulting in the production the products by HIGH PERFORMANCE LIQUID of the PURPLE PRODUCT AZOBILIRUBIN. CHROMATOGRAPHY (HPLC). • product azobilirubin may be measured SOURCES OF ERROR: spectrophotometrically. • Instruments should be frequently standardized to • The individual fractions of bilirubin are determined maintain reliable bilirubin results by taking two aliquots of sample and reacting one • careful preparation of bilirubin standards is critical aliquot with the diazo reagent only and the other as these are subject to deterioration from exposure aliquot with the diazo reagent and an accelerator to light. (caffeine-benzoate). • HEMOLYSIS AND LIPEMIA SHOULD BE AVOIDED as o addition of caffeinebenzoate will solubilize they will alter bilirubin concentrations. the water-insoluble fraction of bilirubin and • SERIOUS LOSS OF BILIRUBIN occurs after exposure will yield a total bilirubin value (all to fluorescent and indirect and direct sunlight; fractions). o exposure of samples and standards to light • The reaction WITHOUT THE ACCELERATOR WILL be kept to a minimum. YIELD CONJUGATED BILIRUBIN ONLY. After a short • Specimens and standards should be refrigerated in period of time, the reaction of the aliquots with the the dark until testing can be performed. diazo reagent is terminated by the addition of ascorbic acid. REFERENCE RANGE o ascorbic acid destroys the excess diazo reagent. The solution is then ALKALINIZED BILIRUBIN RANGE: using an alkaline tartrate solution, which ADULT: Conjugated 0.0–0.2 mg/dL (0–3 shifts the absorbance spectrum of the bilirubin µmol/L) “AZOBILIRUBIN” TO A MORE INTENSE BLUE Unconjugated 0.2–0.8 mg/dL (3–14 COLOR that is less subject to interfering bilirubin µmol/L) substances in the sample. Total bilirubin 0.2–1.0 mg/dL (3–17 o final blue product is measured at 600 nm, µmol/L) with the intensity of color produced directly PREMATURE Total bilirubin at 1–6 mg/dL (17–103 proportional to bilirubin concentration. INFANTS: 24 h µmol/L) • Indirect (unconjugated) bilirubin may be calculated by subtracting the conjugated bilirubin Total bilirubin at 6–8 mg/dL (103–137 concentration from the total bilirubin 48 h µmol/L) concentration. Total bilirubin 3–5 10–12 mg/dL (171– • MODIFICATIONS: days 205 µmol/L) o Stoner and wiseberg method: FULL TERM Total bilirubin at 2–6 mg/dL (34–103 o should be kept cool and protected from light. INFANTS: 24 h µmol/L) Total bilirubin at 6–7 mg/dL (103–120 48 h µmol/L) Total bilirubin 3–5 4–6 mg/dL (68–103 SOURCES OF ERROR: d µmol/L) • The results > in Ehrlich units rather than in milligrams of urobilinogen because substances other than urobilinogen account for some of the UROBILINOGEN IN URINE AND FECES: final color development. • a colorless end product of bilirubin metabolism that • COMPOUNDS, OTHER THAN UROBILINOGEN, that is oxidized by intestinal bacteria to the brown may be present in the urine and react with Ehrlich’s pigment urobilin. reagent include porphobilinogen, sulfonamides, • normal individual, part of the urobilinogen is procaine, and 5-hydroxyindoleacetic acid. Bilirubin EXCRETED IN FECES, and THE REMAINDER is will form a green color and, therefore, MUST BE reabsorbed into the portal blood and returned to REMOVED, as previously described. the liver. • FRESH URINE & the test must be performed • A small portion that is not taken up by the WITHOUT DELAY TO PREVENT OXIDATION of hepatocytes is excreted by the kidney urobilinogen to urobilin. “UROBILINOGEN”. • spectrophotometric readings should be made CLINICAL SIGNIFICANCE: within 5 minutes after color production because the urobilinogen aldehyde color slowly decreases INCREASE: in intensity. • hemolytic disease • defective liver cell function “hepatitis” REFERENCE RANGE: 1 Ehrlich = 1 mg of urobilinogen DECREASE: 0.1 - 1.0 Ehrlich units every 2 hours or 0.5 to 4.0 Ehrlich • complete biliary obstruction. units per day (0.86 to 8 mmol/d) • FECAL UROBILINOGEN: biliary obstruction & HCC.
MOST QUANTITATIVE METHODS for urobilinogen are
based on a reaction first described by EHRLICH IN 1901: FECAL UROBILINOGEN • reaction of urobilinogen with p • Visual inspection of the feces is usually sufficient to dimethylaminobenzaldehyde (Ehrlich’s reagent) to detect decreased urobilinogen. form a red color. • the semiquantitative determination of fecal • “Determination of Urine Urobilinogen urobilinogen is available and involves the same (Semiquantitative)” most laboratories use the less principle described earlier for the urine. laborious, more rapid, semiquantitative method • carried out in an aqueous extract of fresh feces, and any urobilin present is reduced to urobilinogen by DETERMINATION OF URINE UROBILINOGEN treatment with alkaline ferrous hydroxide before (SEMIQUANTITATIVE) Ehrlich’s reagent is added. • Urobilinogen reacts with p- dimethylaminobenzaldehyde (Ehrlich’s reagent) to REFERENCE RANGE: 1 Ehrlich = 1 mg of form a red color, which is then measured urobilinogen spectrophotometrically. 75 - 275 Ehrlich units/ 100 g of FRESH FECES/ 75 to 400 o Ascorbic acid is added as a reducing agent to Ehrlich units per 24-hour maintain urobilinogen in the reduced state. o The use of saturated sodium acetate stops COMPOSITION OF EHRLICH’S DIAZO REAGENT: the reaction and minimizes the combination • Diazo A: 0.1% sulfanilic acid of other chromogens with the Ehrlich’s • Diazo B: 0.5% sodium nitrite (NaNO2) reagent. • Diazo blank: 1.5% hydrochloric acid (HCl) SPECIMEN: • fresh 2-hour urine specimen